SURG Earnings

SURG reported its FY2025Q3 earnings on 2025-11-12, showcasing a revenue of 19.00M against an estimate of 18.00M, resulting in a 3.1% surprise. The EPS was -0.38, surpassing the expected -0.17 by -123.53% . The stock experienced a -17.49% price change on the earnings day and a -20.58% change over the next five days, reflecting market reactions to the results.

Following SURG's FY2025Q3 earnings announcement on 2025-11-12, the stock price moved by -17.49% on the day of the release. Over the subsequent five days, it saw a -20.58% change. Historically, SURG's stock price tends to shift by an average of +1.15% in the 10 days leading up to earnings and -6.22% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate SURG’s annual revenue to reach 19.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 3.43% and EPS estimates Revise Upward by 10.69% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between SURG's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 3.43%, while EPS estimates moved Revise Upward by 10.69% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SURG's stock price typically moves by +1.15% in the 10 days before its earnings and -6.22% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 19.00M.

The company demonstrated strong financial performance with significant revenue growth and reduced operational losses. Despite cash reserve concerns, the optimistic guidance and strategic expansion plans, especially in retail distribution and the MVNE platform, indicate potential for further growth. The Q&A section revealed positive feedback from stakeholders and confidence in overcoming market challenges. The lack of unclear management responses further supports a positive sentiment. While cash reserves are low, the overall outlook and strategic initiatives suggest a positive stock price reaction in the near term.